Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.01 -0.02 (-2.40%)
As of: Sep 10, 2026 · 1:33 PM EDT

Creative Medical Technology Holdings (CELZ) Operating Margin Growth (1y) (2018 - 2025)

Analysis

Creative Medical Technology Holdings (CELZ) Operating Margin Growth (1y) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Krystal Biotech 10.26 Bn 9.42 Bn 112.79 Mn 798.00
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn - 2.46 Mn
3 Iovance Biotherapeutics 3.66 Bn 3.36 Bn 55.72 Mn 13,751.00
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 2,348.00
5 uniQure 3.01 Bn 3.01 Bn 5.49 Mn -6,012.00
6 Beam Therapeutics 2.53 Bn 2.53 Bn - -2.44 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 375,193.00
8 Sarepta Therapeutics 2.16 Bn 1.36 Bn 251.87 Mn -1,560.00
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 377.00
10 Creative Medical Technology Holdings 1.41 Mn 1.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -200,160.00
Dec 31, 2024 -379,650.00
Dec 31, 2023 -2.53 Mn
Sep 30, 2023 -2.39 Mn
Dec 31, 2022 -3.16 Mn
Sep 30, 2022 647,905.00
Dec 31, 2021 -32,756.00
Sep 30, 2021 -801,946.00
Jun 30, 2021 -439,045.00
Dec 31, 2020 -935,947.00
Sep 30, 2020 16,062.00
Jun 30, 2020 -32,080.00
Mar 31, 2020 -30,231.00
Dec 31, 2019 806,954.00
Sep 30, 2019 4,898.00
Jun 30, 2019 611,179.00
Mar 31, 2019 163,375.00
Dec 31, 2018 456,822.00